Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia

Autor: Yeh, Jason, Pasvolsky, Oren, Saliba, Rima M., Figgins, Bradley, Wang, Christopher, Fang, Zhou, Ahmed, Sairah, Yilmaz, Musa, Daver, Naval, Ravandi, Farhad, DiNardo, Courtney, Short, Nicholas J., Kadia, Tapan, Al-Atrash, Gheath, Daher, May, Costa, David Marin, Popat, Uday, Champlin, Richard, Shpall, Elizabeth, Oran, Betül
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia November 2024 24(11):e819-e826
Databáze: ScienceDirect
Externí odkaz: